Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer.
Ricciuti B, Fusco F, Cooper A, Garbo E, Pecci F, Aldea M, Wang X, Mayoral Penalva M, Ginsberg M, Sholl LM, Nishino M, Di Federico A, Shaverdian N, Bott M, Santo V, Rendina E, Trisolini R, Ramella S, Gallina F, Melis E, Buglioni S, Minuti G, Landi L, Ugalde Figueroa PA, Shaw AT, Chaft J, Awad MM, Cappuzzo F.
Definitive Radiation Therapy for Angiosarcoma of the Face and Scalp.
Suzuki G, Yamazaki H, Takenaka H, Aibe N, Masui K, Kimoto T, Tatekawa K, Nakashima A, Takenaka T, Asai J, Komori S, Wada M, Katoh N, Yamada K.
In Vivo. 2016 11-12;30(6):921-926. doi: 10.21873/invivo.11014.
PMID:27815481
Gynecological malignancies.
Schaebler DL, Schilder RJ, Young RC.
Cancer Chemother Biol Response Modif. 1996;16:564-91.
PMID:8639401
Hirsutism as the initial presentation of malignant ovarian Leydig cell tumor: A case report.
Arafat H, Khaldy M, Abu Munshar A, Zughayyer A.
Clin Case Rep. 2023 Oct 18;11(10):e7915. doi: 10.1002/ccr3.7915. eCollection 2023 Oct.
PMID:37867539
Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy.